Penn Otorhinolaryngology – Head and Neck Surgery (ENT) provides expert, innovative care for trauma and disease affecting the head and neck — with a particular focus on challenging and rare cases.
Our clinical team includes internationally-recognized surgeons and researchers who have devoted their careers to specific regions of the head and neck — the oropharynx, ear, nasal septum, thyroid, cranial-base, tongue, throat and salivary ductal system — to provide unparalleled care for patients with unusual or complicated conditions. Which is why physicians refer their most complex ENT patients to Penn Medicine more often than any other hospital in the Philadelphia region.
A History of Innovation at Penn ENT
"It takes physicians and clinical researchers working together to translate scientific discoveries into treatments that help patients," explained Bert W. O'Malley, Jr., MD, Chair, Department of Otorhinolaryngology — Head and Neck Surgery and Co-Director, Head and Neck Cancer Center. "We have a history of pioneering new approaches here because we're always seeking better treatments and outcomes, and the best care for our patients," he continued. "The pursuit of better care is always at the forefront of our achievements. It's a consistent, key theme of our research efforts at Penn."
Penn ENT Therapies and Research: Updates and Resources
TransOral Robotic Surgery (TORS)
TORS is the world's first minimally-invasive, transoral robot-assisted procedure for head and neck cancer surgery. Developed at Penn by Drs. O'Malley and Weinstein, TORS was introduced in 2005.
Using TumorGlow® for Head and Neck Surgery
Developed at Penn by Dr. Sunil Singhal and championed internally among a number of specialties, including Penn Otorhinolaryngology, this innovative approach to fluorescent-guided, intraoperative surgery affords unprecedented accuracy in cancer resections in otorhinolaryngologic procedures.
Identifying Genetic Drivers for Head and Neck Cancers
In collaboration with the Abramson Cancer Center, Penn Otorhinolaryngology — Head and Neck Surgery is gathering samples of tumor tissue from patients with node-positive oral squamous cell carcinoma to learn more about changes that occur in DNA and identify biomarkers related to cancer.
Redefining the use of Autologous Cartilage in Rhinoplasty
Penn faculty and a team of residents from Penn ENT conducted a study to ascertain which of the methods (scoring, dicing, shaving and crushing) of manipulating bovine septal cartilage caused more cell stress and death as part of a study to develop techniques and products to improve the stability and viability of cartilage grafting.
Proton Therapy for Advanced Cancers of the Head and Neck
In 2009, Penn Medicine opened the largest proton therapy center in the world. An advance on standard x-ray (photon) therapy, proton therapy deposits a precise beam of radiation over a narrow range with minimal exit dose to treat cancers and other diseases — while sparing healthy tissue.
Additional Penn ENT resources